Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 6.81% is 57% below its 5-year average of 15.72%, around the middle of its 5-year range (-22.94%–38.12%).
30.08% below its 12-month average of 9.74%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-28): -1.64%.
NET PROFIT MARGIN
6.81%
NET PROFIT MARGIN AVG TTM
9.74%
NET PROFIT MARGIN AVG 3Y
7.40%
NET PROFIT MARGIN AVG 5Y
15.72%
NET PROFIT MARGIN AVG 10Y
20.20%
NET PROFIT MARGIN AVG 15Y
20.29%
NET PROFIT MARGIN AVG 20Y
19.00%
CURRENT VS TTM AVG
-30.08%
CURRENT VS 3Y AVG
-8.01%
CURRENT VS 5Y AVG
-56.67%
CURRENT VS 10Y AVG
-66.30%
CURRENT VS 15Y AVG
-66.44%
CURRENT VS 20Y AVG
-64.16%
SECTOR MEDIAN · HEALTHCARE
9.21%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-26.02%
vs the sector median at left
Market Cap
$147.13B
Net Profit Margin
15.95%
TTM Avg
15.52%
3Y Avg
19.51%
5Y Avg
19.37%
Market Cap
$176.59B
Net Profit Margin
11.65%
TTM Avg
23.34%
3Y Avg
19.20%
5Y Avg
17.71%
Market Cap
$133.24B
Net Profit Margin
28.45%
TTM Avg
28.09%
3Y Avg
25.67%
5Y Avg
26.14%
Market Cap
$181.64B
Net Profit Margin
-10.64%
TTM Avg
15.29%
3Y Avg
17.07%
5Y Avg
15.27%
Market Cap
$130.62B
Net Profit Margin
34.89%
TTM Avg
13.94%
3Y Avg
25.44%
5Y Avg
29.40%
Market Cap
$130.18B
Net Profit Margin
18.87%
TTM Avg
-1.95%
3Y Avg
6.91%
5Y Avg
3.60%
Market Cap
$188.86B
Net Profit Margin
35.33%
TTM Avg
33.96%
3Y Avg
33.83%
5Y Avg
33.74%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pfizer Inc. (PFE) | $157.02B | 6.81% | 9.74% | 7.40% | 15.72% |
| Danaher Corporation (DHR)vs › | $147.13B | 15.95% | 15.52% | 19.51% | 19.37% |
| Abbott Laboratories (ABT)vs › | $176.59B | 11.65% | 23.34% | 19.20% | 17.71% |
| Intuitive Surgical, Inc. (ISRG)vs › | $133.24B | 28.45% | 28.09% | 25.67% | 26.14% |
| Gilead Sciences, Inc. (GILD)vs › | $181.64B | -10.64% | 15.29% | 17.07% | 15.27% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $130.62B | 34.89% | 13.94% | 25.44% | 29.40% |
| Bristol-Myers Squibb Company (BMY)vs › | $130.18B | 18.87% | -1.95% | 6.91% | 3.60% |
| Novo Nordisk A/S (NVO)vs › | $188.86B | 35.33% | 33.96% | 33.83% | 33.74% |
| CVS Health Corp. (CVS)vs › | $120.56B | 1.18% | 0.84% | 1.34% | 1.79% |
| Medtronic plc (MDT)vs › | $120.00B | 13.93% | 13.55% | 12.62% | 13.06% |
Operating Margin
25.1%
Net Profit Margin
6.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-28 | -1.64% |
| 2026-03-29 | 18.60% |
| 2025-12-31 | -9.39% |
| 2025-09-28 | 21.26% |
| 2025-06-29 | 19.86% |
| 2025-03-29 | 21.63% |
| 2024-12-31 | 2.27% |
| 2024-09-29 | 25.27% |
| 2024-06-30 | 0.18% |
| 2024-03-31 | 20.97% |
| 2023-12-31 | -22.94% |
| 2023-10-01 | -17.75% |
| 2023-07-02 | 17.91% |
| 2023-04-02 | 29.98% |
| 2022-12-31 | 20.56% |
| 2022-10-02 | 38.12% |
| 2022-07-03 | 35.58% |
| 2022-04-03 | 30.68% |
| 2021-12-31 | 14.23% |
| 2021-10-03 | 33.95% |
| 2021-07-04 | 30.68% |
| 2021-04-04 | 33.60% |
| 2020-12-31 | 7.28% |
| 2020-09-27 | 14.29% |
| 2020-06-28 | 35.37% |
| 2020-03-29 | 33.27% |
| 2019-12-31 | -2.66% |
| 2019-09-29 | 60.57% |
| 2019-06-30 | 38.04% |
| 2019-03-31 | 29.60% |
| 2018-12-31 | -2.82% |
| 2018-09-30 | 30.94% |
| 2018-07-01 | 28.75% |
| 2018-04-01 | 27.58% |
| 2017-12-31 | 89.57% |
| 2017-10-01 | 21.57% |
| 2017-07-02 | 23.84% |
| 2017-04-02 | 24.42% |
| 2016-12-31 | 5.68% |
| 2016-10-02 | 10.12% |
| 2016-07-03 | 15.57% |
| 2016-04-03 | 23.36% |
| 2015-12-31 | -1.22% |
| 2015-09-27 | 17.62% |
| 2015-06-28 | 22.15% |
| 2015-03-29 | 21.86% |
| 2014-12-31 | 9.36% |
| 2014-09-28 | 21.57% |
| 2014-06-29 | 22.79% |
| 2014-03-30 | 20.51% |
| 2013-12-31 | 18.93% |
| 2013-09-29 | 20.51% |
| 2013-06-30 | 108.68% |
| 2013-03-31 | 20.37% |
| 2012-12-31 | 41.91% |
| 2012-09-30 | 22.95% |
| 2012-07-01 | 21.60% |
| 2012-04-01 | 11.65% |
| 2011-12-31 | 8.59% |
| 2011-10-02 | 21.74% |
| 2011-07-03 | 15.37% |
| 2011-04-03 | 13.47% |
| 2010-12-31 | 16.46% |
| 2010-10-03 | 5.36% |
| 2010-07-04 | 14.28% |
| 2010-04-04 | 12.10% |
| 2009-12-31 | 4.64% |
| 2009-09-27 | 24.77% |
| 2009-06-28 | 20.58% |
| 2009-03-29 | 25.11% |
| 2008-12-31 | 2.15% |
| 2008-09-28 | 19.03% |
| 2008-06-29 | 22.89% |
| 2008-03-30 | 23.50% |
| 2007-12-31 | 21.16% |
| 2007-09-30 | 6.34% |
| 2007-07-01 | 11.42% |
| 2007-04-01 | 27.18% |
| 2006-12-31 | 74.97% |
| 2006-10-01 | 27.37% |
| 2006-07-02 | 20.55% |
| 2006-04-02 | 32.47% |
| 2005-12-31 | 20.09% |
| 2005-10-02 | 13.03% |
| 2005-07-03 | 27.86% |
| 2005-04-03 | 2.30% |
| 2004-12-31 | 18.92% |
| 2004-09-26 | 26.03% |
| 2004-06-27 | 23.32% |
| 2004-03-28 | 18.66% |
| 2003-12-31 | 4.24% |
| 2003-09-28 | 17.87% |
| 2003-06-29 | -35.94% |
| 2003-03-30 | 54.72% |
| 2002-12-31 | 39.69% |
| 2002-09-29 | 26.93% |
